124 related articles for article (PubMed ID: 9822332)
1. Are serum type III procollagen and prolyl hydroxylase useful as noninvasive markers of liver disease in patients with cystic fibrosis?
Leonardi S; Giambusso F; Sciuto C; Castiglione S; Castiglione N; La Rosa M
J Pediatr Gastroenterol Nutr; 1998 Nov; 27(5):603-5. PubMed ID: 9822332
[No Abstract] [Full Text] [Related]
2. [Clinical significance of serum prolyl hydroxylase in diabetic microangiopathy].
Shioi A; Nishizawa Y; Morii H
Nihon Rinsho; 1998 Jan; 56 Suppl 3():126-8. PubMed ID: 9513402
[No Abstract] [Full Text] [Related]
3. Clinical significance of serum 7S collagen in various liver diseases.
Yamada S; Suou T; Kawasaki H; Yoshikawa N
Clin Biochem; 1992 Dec; 25(6):467-70. PubMed ID: 1335851
[TBL] [Abstract][Full Text] [Related]
4. A comparison of four serum markers of fibrosis in the diagnosis of cirrhosis.
Fabris C; Falleti E; Federico E; Toniutto P; Pirisi M
Ann Clin Biochem; 1997 Mar; 34 ( Pt 2)():151-5. PubMed ID: 9133247
[TBL] [Abstract][Full Text] [Related]
5. Serum markers for hepatic fibrosis in alcoholic liver disease: which is the best marker, type III procollagen, type IV collagen, laminin, tissue inhibitor of metalloproteinase, or prolyl hydroxylase?
Tsutsumi M; Takase S; Urashima S; Ueshima Y; Kawahara H; Takada A
Alcohol Clin Exp Res; 1996 Dec; 20(9):1512-7. PubMed ID: 8986196
[TBL] [Abstract][Full Text] [Related]
6. Enzymes of collagen synthesis and type III procollagen amino-propeptide in serum from Nigerians with chronic endomyocardial fibrosis.
Bolarin DM; Andy JJ
Ann Clin Res; 1983 Jun; 15(3):123-7. PubMed ID: 6314867
[TBL] [Abstract][Full Text] [Related]
7. Serum enzymes of collagen synthesis and type III procollagen amino-propeptide in Nigerian patients with sickle cell disease.
Bolarin M
J Clin Chem Clin Biochem; 1986 Jul; 24(7):433-6. PubMed ID: 3016143
[TBL] [Abstract][Full Text] [Related]
8. Serum markers of hepatic fibrogenesis in cystic fibrosis liver disease.
Pereira TN; Lewindon PJ; Smith JL; Murphy TL; Lincoln DJ; Shepherd RW; Ramm GA
J Hepatol; 2004 Oct; 41(4):576-83. PubMed ID: 15464237
[TBL] [Abstract][Full Text] [Related]
9. Human prolyl-hydroxylase: only a marker of hepatic damage?
Tamaro G; Pozzato G; Moretti M
Int J Clin Lab Res; 1993; 23(4):228. PubMed ID: 8123880
[No Abstract] [Full Text] [Related]
10. [Hepatic fibrosis and its serum markers].
Okabe K
Rinsho Byori; 1992 Dec; 40(12):1258-64. PubMed ID: 1339165
[TBL] [Abstract][Full Text] [Related]
11. Serum immunoreactive prolyl 4-hydroxylase as a specific marker of hepatocellular necrosis.
Nagai Y; Toda G
Clin Chim Acta; 1990 Sep; 190(1-2):109-10. PubMed ID: 2170064
[No Abstract] [Full Text] [Related]
12. [Assay of serum collagen markers in chronic liver diseases and liver cancer].
Inoue T; Funaki N; Hatahara T; Igarashi S; Kaneko E; Tanaka H
Nihon Shokakibyo Gakkai Zasshi; 1990 Jul; 87(7):1506-13. PubMed ID: 2170716
[TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of serum prolyl hydroxylase analysis in the diagnosis of diabetic diseases].
Shioi A; Nishizawa Y; Morii H
Nihon Rinsho; 1990 Dec; 48 Suppl():370-3. PubMed ID: 1964975
[No Abstract] [Full Text] [Related]
14. Is serum prolyl 4-hydroxylase useful as noninvasive marker of liver fibrosis in patients with biliary atresia?
Kobayashi H; Tamura T; Yamataka A; Lane GJ; Miyano T
J Pediatr Surg; 2005 Aug; 40(8):1366-7. PubMed ID: 16080952
[No Abstract] [Full Text] [Related]
15. [Type III procollagen N-terminal peptide (P-III-P, prolyl hydroxylase (PH), and laminin P1 levels in serum and BALF of radiotherapy patients].
Matsumoto S; Shindo J; Horiba M; Hara M; Inoue K
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Jan; 30(1):28-34. PubMed ID: 1320708
[TBL] [Abstract][Full Text] [Related]
16. Elevation of laminin and beta-subunit of prolyl 4-hydroxylase in the sera of human subjects with Schistosomiasis mansoni.
Tanabe M; Sekiguchi T; Kaneko N; Kobayashi S; Takeuchi T; Coutinho A; Tateno S; Maruyama K; Okazaki I
Jpn J Exp Med; 1989 Jun; 59(3):109-19. PubMed ID: 2554032
[TBL] [Abstract][Full Text] [Related]
17. Serum immunoreactive prolyl hydroxylase in liver disease.
Tuderman L; Risteli J; Miettinen TA; Kivirikko KI
Eur J Clin Invest; 1977 Dec; 7(6):537-41. PubMed ID: 204493
[TBL] [Abstract][Full Text] [Related]
18. A sandwich immunoassay for human prolyl 4-hydroxylase using monoclonal antibody.
Yoshida S; Bai Y; Muragaki Y; Ooshima A; Inada K; Nagai Y; Obata K; Iwata K; Hashida S; Ishikawa E
Clin Chim Acta; 1986 Oct; 160(1):37-46. PubMed ID: 3021363
[TBL] [Abstract][Full Text] [Related]
19. Prolylhydroxylase and procollagen type III in long-term survivors of acute lymphoblastic leukemia (ALL): a biochemical approach to HCV-related liver disease.
Leonardi S; La Spina M; La Rosa M; Schilirò G
Med Pediatr Oncol; 2003 Jul; 41(1):17-20. PubMed ID: 12764737
[TBL] [Abstract][Full Text] [Related]
20. Prolyl hydroxylase and procollagen III peptide levels in the sera from patients with collagen diseases and psoriasis.
Sasaki T; Nakajima H
J Dermatol; 1989 Jun; 16(3):207-11. PubMed ID: 2551942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
